PTGX Protagonist Therapeutics, Inc.

NASDAQ
$142.84

Protagonist Therapeutics, Inc. (PTGX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with PTGX's own trailing one-year pace, with 1% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
38 transactions
Purchases
$0
0 shares
Sales
$88.1M
808,224 shares
Net activity
-$88.1M
purchases less sales

How much of that selling was preplanned? 1% planned / 99% discretionary

10b5-1 plan sales $1.2M 3 transactions · 16,000 shares
Discretionary sales $86.9M 35 transactions · 792,224 shares

Largest single sale: $9.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
PATEL DINESH V PH D President and CEO Sell 7,278 $144.10 $1.0M 522,968 −1.4% of holding
PATEL DINESH V PH D President and CEO Sell 63,548 $146.18 $9.3M 522,968 −10.8% of holding
PATEL DINESH V PH D President and CEO Sell 54,174 $145.87 $7.9M 522,968 −9.4% of holding
PATEL DINESH V PH D President and CEO Sell 34,239 $148.52 $5.1M 523,478 −6.1% of holding
PATEL DINESH V PH D President and CEO Sell 65,761 $149.11 $9.8M 523,478 −11.2% of holding
Waddill William D. Director Sell 9,000 $117.94 $1.1M 7,825 −53.5% of holding
Waddill William D. Director Sell 9,000 $107.68 $969.1K 7,825 −53.5% of holding
Waddill William D. Director Sell 9,000 $99.64 $896.8K 7,825 −53.5% of holding
PATEL DINESH V PH D 2 fills President and CEO Sell 150,000 $100.12 $15.0M 523,478 −22.3% of holding
Giraudo Bryan 2 fills Director Sell 11,130 $100.00 $1.1M 12,695 −46.7% of holding
Giraudo Bryan 2 fills Director Sell 48,000 $100.12 $4.8M 27,825 −63.3% of holding
Ali Asif Chief Financial Officer Sell 1,750 $105.47 $184.6K 59,003 −2.9% of holding
Ali Asif Chief Financial Officer Sell 24,765 $104.24 $2.6M 60,753 −29% of holding
SELICK HAROLD E Director Sell 24,000 $105.00 $2.5M 60,845 −28.3% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 15,000 $104.79 $1.6M 84,115 −15.1% of holding
PATEL DINESH V PH D President and CEO Sell 54,641 $101.00 $5.5M 524,938 −9.4% of holding
PATEL DINESH V PH D President and CEO Sell 59 $101.00 $6.0K 524,938 −0% of holding
Williams Lewis T Director Sell 18,000 $82.42 $1.5M 7,825 −69.7% of holding
Waddill William D. Director Sell 20,000 $83.68 $1.7M 7,825 −71.9% of holding
Ali Asif 2 fills Chief Financial Officer Sell 46,203 $83.13 $3.8M 78,523 −37% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 5,000 $82.00 $410.0K 84,115 −5.6% of holding
PATEL DINESH V PH D President and CEO Sell 4,068 $83.19 $338.4K 574,505 −0.7% of holding
PATEL DINESH V PH D 2 fills President and CEO Sell 24,890 $84.03 $2.1M 574,505 −4.2% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 5,000 $82.28 $411.4K 84,115 −5.6% of holding
PATEL DINESH V PH D President and CEO Sell 19,315 $84.59 $1.6M 574,505 −3.3% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 13,151 $82.42 $1.1M 84,115 −13.5% of holding
PATEL DINESH V PH D President and CEO Sell 34,438 $82.48 $2.8M 580,505 −5.6% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 9,514 $82.48 $784.7K 97,266 −8.9% of holding
Ali Asif Chief Financial Officer Sell 8,588 $82.48 $708.3K 78,077 −9.9% of holding
MOLINA ARTURO MD Chief Medical Officer Sell 2,712 $84.77 $229.9K 81,180 −3.2% of holding
Waddill William D. 2 fills Director Sell 10b5-1 12,000 $81.62 $979.5K 13,130 −47.8% of holding
Waddill William D. Director Sell 10b5-1 4,000 $64.25 $257.0K 5,130 −43.8% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.